Medication info
Diodipin Tablet 5/160 milligrams

Diodipin Tablet 5/160 milligrams

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Aliko Pharmaceutical Co., Ltd.
Appearance
Dark yellow, egg-shaped film-coated tablet
Packaging
PTP packaging - 28 tablets/PTP [14 tablets/PTP x 2]
Approval status
Active

MFDS item code 201600178 · Approved 2016.01.08 · Insurance code 656004100

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medicine may be considered as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance ≥10mL/min); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance <10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
This medicine is not recommended for use in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Aliko Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or valsartan.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medicine may be considered as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance ≥10mL/min); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance <10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

This medicine is not recommended for use in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus, particularly during the second and third trimesters of pregnancy, so if pregnancy is confirmed, it should be discontinued immediately. Individuals with allergies to this drug's main ingredients or related components, pregnant or nursing women, and those with severe kidney or liver disease should not take this medication. Patients with reduced sodium or fluid in their bodies may experience low blood pressure, so their condition should be closely monitored prior to use and it should be used under medical supervision. Patients with high potassium levels should be cautious when taking this medication alongside potassium-increasing medications, and regular potassium level checks are necessary. Patients with renal vascular problems or those who have undergone kidney transplants should use this medication with caution, as kidney function may deteriorate during treatment. If symptoms of angioedema (airway obstruction or swelling of the face, lips, tongue) occur, discontinue use immediately and do not resume. Patients with heart failure or post-myocardial infarction should frequently monitor kidney function and blood pressure while using this medication, considering the potential for worsening heart failure. Patients with acute myocardial infarction or heart disease such as aortic stenosis should use this medication with special caution. Using this medication alongside other antihypertensives can increase the risk of hypotension, hyperkalemia, and kidney impairment, so consultation with a doctor is necessary. There may be dizziness or fatigue when driving or operating machinery, so caution is advised. In the case of overdose, severe hypotension or heart-related issues may occur, so the dosage must be adhered to, and any unusual symptoms should be reported to medical personnel immediately. This medication is not recommended for pediatric patients under 18 years of age, as safety and efficacy have not been established. Older adults can use similar doses as regular adults, but should follow doctor's instructions based on their health status.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, position-related dizziness, sensory disturbances, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, sweating, itching, joint swelling, low back pain, arthritis, muscle cramps, lethargy, polyuria, nocturia, erectile dysfunction, edema, local edema, facial swelling, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, kidney failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disorder, peripheral neuropathy, excessive muscle tone, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival polymorphism, gastritis, neuroexcitability, sensory loss, Stevens-Johnson syndrome, dizziness, fatigue, sudden drop in blood pressure, hypotension, pulmonary edema, decreased urine output, progressive hyperazotemia, acute kidney failure, death, angina, acute myocardial infarction, increased blood urea, increased serum creatinine, intestinal vascular edema, abdominal pain, nausea, vomiting, diarrhea, non-cardiogenic pulmonary edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is important to keep it at a temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Dark yellow, egg-shaped film-coated tablet

Package unit

PTP packaging - 28 tablets/PTP [14 tablets/PTP x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.